[SYRE] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
29-Dec-2022
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -3.22%
YoY- 7.94%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 0 688 198 168 174 625 1,362 -
PBT -40,104 -217,074 -18,458 -18,784 -18,443 -22,314 -24,436 39.09%
Tax 3 7 -36 38 -209 9 0 -
NP -40,107 -217,081 -18,422 -18,822 -18,234 -22,323 -24,436 39.10%
Tax Rate - - - - - - - -
Total Cost 40,107 217,769 18,620 18,990 18,408 22,948 25,798 34.16%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 0.00 -31,552.47 -9,304.04 -11,203.57 -10,479.31 -3,571.68 -1,794.13 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -9.34 -56.79 -4.89 -7.20 -4.84 -6.79 -9.26 0.57%
EPS Diluted -9.34 -56.79 -4.89 -7.20 -4.84 -6.79 -9.26 0.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.